IL2 and neoplasm: Immunotherapy using IL-2 has been shown to have moderate success against some tumors and is often associated with “unexpected” but significant eosinophilia [27], which resulted in assumptions suggesting that eosinophils possess anti-tumor activity, at least in vitro[28].